<DOC>
	<DOCNO>NCT02549443</DOCNO>
	<brief_summary>This study evaluate whether provide nutritional intervention form insulin , sugar protein open-heart surgery increase body 's protein store maintain normal level blood sugar . The primary outcome Whole body protein balance assess isotope tracer kinetics . Protein balance calculate protein synthesis minus protein breakdown positive value indicate anabolism negative value catabolism . The preoperative measurement perform morning operation . Postoperative study conduct two hour surgery intensive care unit . Patients follow 12 hour surgery .</brief_summary>
	<brief_title>The Anabolic Effect Of Perioperative Nutrition With Insulin In Patients Undergoing CABG</brief_title>
	<detailed_description>Open heart surgery associate catabolic response characterize hyperglycemia whole body protein loss . Results previous study demonstrate reduction whole-body protein breakdown synthesis patient receive insulin isocaloric amount glucose ( hyperinsulinemic-normoglycemic clamp , HNC ) coronary artery bypass graft ( CABG ) surgery . Because protein oxidation change circulate concentration amino acid decrease ( hypoaminoacidemia ) presence insulin therapy whole-body protein balance remain negative , ie patient still catabolic . The investigator hypothesize lack anabolic effect due absence anabolic substrate supply ( amino acid ) . The primary objective study test hypothesis insulin administer part hyperinsulinemic-normoglycemic clamp immediately CABG : 1 . Will induce whole-body positive protein balance supplement intravenous amino acid ( AA ) amount preserve normal AA plasma concentration ( isoaminoacidemia ) , 2 . Will enhance whole-body protein balance combine infusion AA amount increase AA plasma concentration supra-normal level ( hyperaminoacidemia ) The primary outcome , whole body protein balance , measure 2 hour surgery intensive care unit . Secondary objective include ( 1 ) measure hepatic albumin synthesis ( 2 ) ass change metabolic-endocrine milieu . Methods : 30 patient schedule elective CABG surgery require cardiopulmonary bypass enrol . Consenting patient divide randomly 3 group . Patients group 1 receive HNC beginning surgery end eight-hour study period surgery . No amino acid give . Patients group 2 receive HNC AA ( Travasol Baxter , Deerfield IL ) surgery amount equivalent 20 % patient 's energy expenditure ( EE ) measure surgery maintain isoaminoacidemia . Patients group 3 receive HNC Travasol iduring surgery amount equivalent 35 % patient 's EE promote hyperaminoacidemia . HNC consist insulin infusion 5 mU/kg/min couple variable infusion glucose ( dextrose 20 % ) maintain normoglycemia ( 4-6 mmol/L ) . Whole body protein balance assess L- [ 1-13C ] leucine tracer kinetics . Protein balance calculate protein synthesis minus leucine rate appearance ( Ra ) positive value indicate anabolism negative value catabolism . Whole body glucose metabolism assess stable isotope tracer [ 6,6-2H2 ] glucose . Hepatic albumin synthesis determine use prim continuous infusion L- [ 2H5 ] phenylalanine . The preoperative measurement perform morning operation . Postoperative study conduct 2 hour surgery intensive care unit . Patients follow 12 hour surgery . Whole body leucine kinetics two group analyze use ANOVA repeat measurement . Statistical significance set P &lt; 0.05 . All p-values present 2-tailed . Tracer kinetics : Whole body leucine glucose metabolism measurement make postabsorptive condition day surgery , postoperatively , intensive care unit . Plasma kinetics glucose leucine , i.e . glucose leucine rate appearance ( Ra ) , leucine oxidation non-oxidative leucine disposal , determine prim constant infusion tracer quantities L- [ 1-13C ] leucine [ 6,6-2H2 ] glucose . Blood expire air sample collect , infusion , analyze baseline enrichment . Priming dos NaH13CO3 ( 1 µmol/kg , po ) , L- [ 1-13C ] leucine ( 4 µmol/kg , iv ) [ 6,6-2H2 ] glucose ( 22 µmol/kg , iv ) , administer follow infusion L- [ 1-13C ] leucine ( 0.06 µmol.kg-1.min-1 ) [ 6,6-2H2 ] glucose ( 0.44 µmol.kg-1.min-1 ) . For determination 13CO2 isotope enrichment four expire breath sample take 150 , 160 , 170 180 minute isotope infusion . Whole body leucine glucose kinetics calculate conventional isotope dilution technique use two-pool random model steady state condition . At isotopic steady state Ra unlabeled substrate plasma derive plasma isotope enrichment , express MPE , accord follow equation : Ra = I . ( MPEinf/MPEpl - 1 ) , I infusion rate tracer , MPEinf enrichment tracer infusate MPEpl tracer enrichment plasma . The final MPE value represent mean MPE measurement isotopic plateau . Isotopic steady state condition regard valid CV MPE value isotopic plateau &lt; 5 % . At isotopic steady state leucine flux ( Q ) quantify follow formula : Q = S+O = B+I , S rate synthesis protein leucine , O rate oxidation , B protein breakdown I dietary intake . Furthermore Q equal Ra ( Ra = B+I ) rate disappearance ( Rd ; Rd = S+O ) . When tracer study do fast state , leucine flux equal B . The rate protein synthesis calculate subtract leucine oxidation leucine flux ( S = Q-O ) . Protein balance calculate protein synthesis minus leucine Ra positive value indicate anabolism negative value catabolism . Plasma [ 1-13C ] α-KIC use calculate flux oxidation leucine . The α-KIC form intracellularly leucine release systemic circulation . It reflect intracellular precursor pool enrichment accurately plasma leucine .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Anabolic Agents</mesh_term>
	<criteria>Patients schedule elective CABG Severe malnutrition ( weight loss &gt; 20 % preceeding 3 month , low albumin level &lt; 35 g/L body mass index &lt; 20 kg/m2 ) , obesity ( body mass index &gt; 35 kg/m2 ) , chronic liver disease ( cirrhosis , document chronic viral hepatitis abnormal liver function test ) , leave ventricular ejection fraction &lt; 30 % , active cancer , dialysis , &lt; 18 year age .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Catabolic response</keyword>
	<keyword>Amino Acids</keyword>
	<keyword>Insulin</keyword>
</DOC>